Robert Rostomily
Overview
Explore the profile of Robert Rostomily including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
578
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Delegard J, et al.
bioRxiv
. 2024 Apr;
PMID: 38586048
Precision oncology is driven by molecular biomarkers. For glioblastoma multiforme (GBM), the most common malignant adult primary brain tumor, O6-methylguanine-DNA methyltransferase ( ) gene DNA promoter methylation is an important...
2.
Ren D, Cheng H, Wang X, Vishnoi M, Teh B, Rostomily R, et al.
Ther Adv Med Oncol
. 2020 Jul;
12:1758835920936151.
PMID: 32655700
Systemic therapies for primary breast cancer have made great progress over the past two decades. However, oncologists confront an insidious and particularly difficult problem: in those patients with metastatic breast...
3.
Haque W, Thong Y, Verma V, Rostomily R, Butler E, Teh B
J Clin Neurosci
. 2020 Feb;
74:155-159.
PMID: 32089384
Background: Glioblastoma (GBM) presents as a solitary lesion (unifocal), or as multiple discrete lesions (multifocal). Multifocal GBM may have a worse prognosis as compared to unifocal GBM, but existing data...
4.
Parada C, Osbun J, Busald T, Karasozen Y, Kaur S, Shi M, et al.
Clin Cancer Res
. 2019 Oct;
26(1):193-205.
PMID: 31615938
Purpose: Most World Health Organization (WHO) grade I meningiomas carry a favorable prognosis. Some become clinically aggressive with recurrence, invasion, and resistance to conventional therapies (grade 1.5; recurrent/progressive WHO grade...
5.
Wong K, Rostomily R, Wong S
Cancers (Basel)
. 2019 Jan;
11(1).
PMID: 30626092
This study aims to discover genes with prognostic potential for glioblastoma (GBM) patients' survival in a patient group that has gone through standard of care treatments including surgeries and chemotherapies,...
6.
Parada C, Osbun J, Kaur S, Yakkioui Y, Shi M, Pan C, et al.
Sci Rep
. 2018 Feb;
8(1):2098.
PMID: 29391485
There is a need to better understand meningioma oncogenesis for biomarker discovery and development of targeted therapies. Histological or genetic criteria do not accurately predict aggressiveness. Post-translational studies in meningioma...
7.
Ramakrishna R, Hebb A, Barber J, Rostomily R, Silbergeld D
Neurosurgery
. 2015 Apr;
77(2):175-84.
PMID: 25850601
Background: Low-grade gliomas (LGGs) comprise a diverse set of intrinsic brain tumors that correlate strongly with survival. Data on the effect of reoperation are sparse. Objective: To evaluate the effect...
8.
Bowdle A, Richebe P, Lee L, Rostomily R, Gabikian P
Ther Drug Monit
. 2014 Sep;
36(5):556-9.
PMID: 25222854
: Lipemic blood was noted in the surgical field by a neurosurgeon after 12.5 hours of anesthesia consisting of infusions of propofol (total dose, 14,956 mcg) and remifentanil (total dose,...
9.
Ramakrishna R, Rostomily R, Sekhar L, Rockhill J, Ferreira M
J Clin Neurosci
. 2013 Nov;
21(4):612-5.
PMID: 24231562
Hemangiopericytomas (HPC) are mesenchymal tumors with a propensity towards chronicity and metastasis. This study aimed to reflect a single institution experience with both World Health Organization (WHO) grade II and...
10.
Di Maio S, Kong E, Yip S, Rostomily R
Surg Neurol Int
. 2013 Jun;
4:72.
PMID: 23776758
Background: Chordomas of the skull base are rare locally aggressive neoplasms with a predilection for encapsulating critical neurovascular structures, bony destruction and irregular growth patterns, and from which patients succumb...